TPST Tempest Therapeutics
- 3.440
- +0.020+0.58%
- 3.300
- -0.140-4.07%
Tempest Therapeutics News
Tempest Therapeutics | ARS: Annual Report to Security Holders
Tempest Therapeutics | DEF 14A: Definitive information statements
Tempest Therapeutics | DEFA14A: Others
Tempest Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Tempest Therapeutics | 10-K: Annual report
Tempest Therapeutics | 8-K: Current report
Tempest Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%), etc.
Tempest Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(0%),Rock Springs Capital LLC(0%), etc.
Tempest Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(2.244%),Abigail P. Johnson(2.244%)
Tempest Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Vantage II, L.P.(11.0%),Versant Vantage II GP, L.P.(11.0%), etc.
Tempest Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brady Stephen R
Tempest Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Whiting Samuel
Tempest Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Trojanowski Justin
Tempest Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Maestas Nicholas
Tempest Therapeutics | S-8 POS: S-8 POS
Tempest Therapeutics | S-8 POS: S-8 POS
Tempest Therapeutics | S-8 POS: S-8 POS
Tempest Therapeutics | S-8 POS: S-8 POS
Tempest Therapeutics | S-8 POS: S-8 POS
Tempest Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Analysis
Price Target
No Data
